Barrett & Company’s iShares Genomics Immunology and Healthcare ETF IDNA Stock Holding History

Barrett & Company’s Portfolio IDNA Stock Details IDNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-750	Closed	-$15.3K	–	625
2023 Q3	$15.3K	Hold	750	–	–	0.01%	375
2023 Q2	$17.5K	Hold	750	–	–	0.01%	364
2023 Q1	$17.5K	Hold	750	–	–	0.01%	340
2022 Q4	$18.9K	Hold	750	–	–	0.01%	323
2022 Q3	$18.9K	Buy	+750	New	+$23.1K	0.01%	323

Other funds holding IDNA

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

WBG

Wharton Business Group Malvern, Pennsylvania $2.65B AUM 20.73% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

CCA

Clearwater Capital Advisors Hoffman Estates, Illinois $1.24B AUM 15.23% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return

Barrett & Company's IDNA Position: Q4 2023 in Review

Barrett & Company sold out of iShares Genomics Immunology and Healthcare ETF (IDNA) in Q4 2023, closing a stake of 750 shares — an estimated $15.3K sold.

Barrett & Company first reported a position in IDNA in Q3 2022 and held it in 5 quarters. The position peaked at $18.9K in Q4 2022. 66 funds tracked by Wall St. Rank hold IDNA as of Q4 2023.

Barrett & Company reported no remaining iShares Genomics Immunology and Healthcare ETF position as of Q4 2023 after selling out during the quarter.
Barrett & Company sold 750 iShares Genomics Immunology and Healthcare ETF shares in Q4 2023, an estimated $15.3K.
Barrett & Company first reported a position in iShares Genomics Immunology and Healthcare ETF in Q3 2022 and held it in 5 quarters.
Barrett & Company's iShares Genomics Immunology and Healthcare ETF position peaked at $18.9K in Q4 2022.
66 funds tracked by Wall St. Rank held iShares Genomics Immunology and Healthcare ETF as of Q4 2023.

Based on Barrett & Company's 13F filing for Q4 2023, filed 24 Jan 2024.